These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25638050)

  • 21. Schizophrenia: into the next millennium.
    Jones B
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent concepts in clinical psychiatry: drug treatment in schizophrenia.
    Hussain SH
    J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive impairment in schizophrenia and how it affects treatment options.
    Bilder RM
    Can J Psychiatry; 1997 Apr; 42(3):255-64. PubMed ID: 9114941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-dopaminergic drugs in schizophrenia].
    Llorca PM
    Encephale; 2006 Oct; 32(5 Pt 4):S913-6; discussion S917. PubMed ID: 17119505
    [No Abstract]   [Full Text] [Related]  

  • 28. Antipsychotics in the treatment of schizophrenia: an overview.
    Tandon R
    J Clin Psychiatry; 2011; 72 Suppl 1():4-8. PubMed ID: 22217436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
    Morrissette DA; Stahl SM
    CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.
    Pickar D; Litman RE; Konicki PE; Wolkowitz OM; Breier A
    Mod Probl Pharmacopsychiatry; 1990; 24():124-51. PubMed ID: 1970851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on dopamine receptors.
    Meador-Woodruff JH
    Ann Clin Psychiatry; 1994 Jun; 6(2):79-90. PubMed ID: 7804392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemistry and neuropharmacology.
    Friedhoff AJ; Pickar D; Axelrod J; Creese I; Davis KL; Gallagher DW; Greengard P; Housman D; Maas JW; Richelson E
    Schizophr Bull; 1988; 14(3):399-412. PubMed ID: 2905525
    [No Abstract]   [Full Text] [Related]  

  • 35. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoamines and schizophrenia.
    Sedvall G
    Acta Psychiatr Scand Suppl; 1990; 358():7-13. PubMed ID: 1978495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cognitive dysfunction in schizophrenia.
    Peuskens J; Demily C; Thibaut F
    Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of schizophrenia and the role of newer antipsychotics.
    Risch SC
    Pharmacotherapy; 1996; 16(1 Pt 2):11-4. PubMed ID: 8778681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology and treatment of negative symptoms.
    Villeneuve A
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.